Skip to main content

Table 3 Univariate analysis of clinical features and risk score with Cox proportional hazard model

From: Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma

Covariates

Overall survival

HR (95%CI)

p Value

Age (< 65 vs. ≥ 65)

1.288 (0.904–1.834)

0.161

Gender (female vs. male)

1.183 (0.823–1.7)

0.363

BMI (< 25 vs. ≥ 25)

1.146 (0.792–1.659)

0.470

Histological grade

 G1

1

 

 G2

1.137 (0.67–1.93)

0.634

 G3

1.202 (0.689–2.095)

0.517

 G4

1.641 (0.606–4.442)

0.33

Clinical stage

 Stage I/II

1

 

 Stage III/IV

2.463 (1.691–3.589)

 < 0.001

T stage

 T1/2

1

 

 T3/4

2.594 (1.813–3.710)

 < 0.001

AFP (< 300 vs. ≥ 300)

1.018 (0.615–1.685)

0.945

Vascular invasion

 None

1

 

 Mico

0.833 (0.519–1.337)

0.449

 Macro

1.284 (0.516–3.193)

0.591

Risk (high vs. low)

2.723 (1.874–3.956)

 < 0.001